pepvax.co Open in urlscan Pro
23.229.238.70  Public Scan

Form analysis
1 forms found in the DOM

POST assets/subscribe.php

<form role="form" action="assets/subscribe.php" method="post">
  <div class="form-group">
    <label class="sr-only" for="subscribe-email">Email address</label>
    <input type="text" name="email" placeholder="Email..." class="subscribe-email" id="subscribe-email">
  </div>
  <div class="g-recaptcha" data-sitekey="6LfIaWEUAAAAAGEFyNRU9H4sihtrP2kvrummBTUe" style="transform:scale(0.77);-webkit-transform:scale(0.77);transform-origin:0 0;-webkit-transform-origin:0 0;">
    <div style="width: 304px; height: 78px;">
      <div><iframe title="reCAPTCHA" width="304" height="78" role="presentation" name="a-i5bcafdrqrqg" frameborder="0" scrolling="no"
          sandbox="allow-forms allow-popups allow-same-origin allow-scripts allow-top-navigation allow-modals allow-popups-to-escape-sandbox allow-storage-access-by-user-activation"
          src="https://www.google.com/recaptcha/api2/anchor?ar=1&amp;k=6LfIaWEUAAAAAGEFyNRU9H4sihtrP2kvrummBTUe&amp;co=aHR0cHM6Ly9wZXB2YXguY286NDQz&amp;hl=en&amp;v=yiNW3R9jkyLVP5-EEZLDzUtA&amp;size=normal&amp;cb=knfdow3sihlr"></iframe></div><textarea
        id="g-recaptcha-response" name="g-recaptcha-response" class="g-recaptcha-response" style="width: 250px; height: 40px; border: 1px solid rgb(193, 193, 193); margin: 10px 25px; padding: 0px; resize: none; display: none;"></textarea>
    </div><iframe style="display: none;"></iframe>
  </div> <br>
  <button type="submit" class="btn">Subscribe</button>
</form>

Text Content

Toggle navigation PepVax - Immunotherapy Revolutionized
 * 
   Home
 * 
   About
   * About PepVax
   * Management Team
   * Board of Directors
   * Board of Advisors
   * Careers
 * 
   Products
   * Technology
 * 
   Partnering
 * 
   Investors & Media
   * Investors
   * Press Releases
   * Events & Presentations
 * 
   Contact

 * 
 * 
 * 

 * 
 * 


ABOUT US


PIPELINE

PepVax has developed novel drug delivery system for large range of diseases...




INVESTORS & MEDIA

Information for investors including market analysis, reports, and...




CAREERS

All PepVax employees strive to make a real difference in patient’s lives. We
look for...




PARTNERS

PepVax would like to partner with larger pharmaceutical companies early in
the...




RECENT NEWS

January, 2018: PepVax Announces Completion of Efficacy Study with Key
Pre-Clinical Data to Validate PVX-009, Addition to its Advisory Board and Other
Updates... Read more...

October, 2017: PEPVAX, INC. WINS “BEST IN SHOW” AT PHILADELPHIA 1ST PITCH LIFE
SCIENCE COMPETITION
Read more...

August, 2017: PEPVAX BEGINS EFFICACY STUDY FOR LEAD CANDIDATE
Read more...

July, 2017: PepVax, Inc., an early stage biotechnology company developing an
immunotherapy treatment for triple-negative breast cancer (TNBC), today
announced several new milestones and upcoming events that demonstrate the
company's continued growth...Read more...

 * 
 * 
 * 
 * 


RECOGNITIONS






ABOUT US

PepVax, Inc. is an early stage life sciences technology company with a novel
DNA-based drug delivery and development platform for proteins, T-cells and
antibodies to be used in cancers, infectious and genetic diseases.

Read more...

EMAIL UPDATES

Enter your email and you'll be one of the first to get new updates:

Email address


Subscribe





TWEETS FROM PEPVAX



CONTACT US

Address: 10411 Motor City Dr., Suite 750, Bethesda, MD 20817

Email: info@pepvax.co



PepVax, Inc. © 2013-2023 | All rights reserved.
Use of this web site constitutes acceptance of the PepVax, Inc. Terms of Use and
Privacy Policy
Website designed by Mahesh Narayanan